BR0110643A - Benzoxazinas para uso no tratamento do mal de parkinson - Google Patents

Benzoxazinas para uso no tratamento do mal de parkinson

Info

Publication number
BR0110643A
BR0110643A BR0110643-0A BR0110643A BR0110643A BR 0110643 A BR0110643 A BR 0110643A BR 0110643 A BR0110643 A BR 0110643A BR 0110643 A BR0110643 A BR 0110643A
Authority
BR
Brazil
Prior art keywords
parkinson
disease
alkyl
benzoxazine
hydrogen
Prior art date
Application number
BR0110643-0A
Other languages
English (en)
Inventor
Corinne Elizab Augelli-Szafran
Thomas Boehme
Roy Douville Schwarz
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of BR0110643A publication Critical patent/BR0110643A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/12—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D498/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

"BENZOXAZINAS PARA USO NO TRATAMENTO DO MAL DE PARKINSON". Benzoxazinas de fórmula (I) onde R^ 1^ é C~ 1~ - C~ 6~ alquila, C~ 2~-C~ 6~ alquenila ou (CH~ 2~)~ n~ fenila, R^ 2^ é C~ 3~ - C~ 6~ alquila, R^ 3^ é hidrogênio, halo, hidróxi, alcóxi ou alquiltio, R^ 4^ é hidrogênio ou alquila, ou um sal farmaceuticamente aceitável das mesmas, são úteis para tratar distúrbios do movimento tal como o mal de Parkinson.
BR0110643-0A 2000-05-09 2001-04-17 Benzoxazinas para uso no tratamento do mal de parkinson BR0110643A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20278700P 2000-05-09 2000-05-09
PCT/US2001/012528 WO2001085734A1 (en) 2000-05-09 2001-04-17 Benzoxazines for use in the treatment of parkinson's disease

Publications (1)

Publication Number Publication Date
BR0110643A true BR0110643A (pt) 2003-03-18

Family

ID=22751255

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0110643-0A BR0110643A (pt) 2000-05-09 2001-04-17 Benzoxazinas para uso no tratamento do mal de parkinson

Country Status (13)

Country Link
US (1) US6812228B2 (pt)
EP (1) EP1282625B1 (pt)
JP (1) JP2003532733A (pt)
AT (1) ATE270295T1 (pt)
AU (1) AU2001251662A1 (pt)
BR (1) BR0110643A (pt)
CA (1) CA2407789A1 (pt)
DE (1) DE60104110T2 (pt)
DK (1) DK1282625T3 (pt)
ES (1) ES2223824T3 (pt)
MX (1) MXPA02010270A (pt)
PT (1) PT1282625E (pt)
WO (1) WO2001085734A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6087916B2 (ja) 2011-07-05 2017-03-01 エレクトロ サイエンティフィック インダストリーズ インコーポレーテッド 使用中の音響光学ビーム偏向器および音響光学変調器の温度安定性を実現するためのシステムならびに方法
US9463186B2 (en) 2013-04-15 2016-10-11 Northwestern University Treatment for dopaminergic disorders
MX2021011588A (es) * 2019-03-25 2021-12-15 Cold Spring Harbor Laboratory Antagonistas del receptor muscarinico de acetilcolina subtipo 4 en el tratamiento de la anemia.

Also Published As

Publication number Publication date
DE60104110T2 (de) 2005-08-25
US6812228B2 (en) 2004-11-02
US20030220335A1 (en) 2003-11-27
ES2223824T3 (es) 2005-03-01
WO2001085734A1 (en) 2001-11-15
MXPA02010270A (es) 2003-04-25
CA2407789A1 (en) 2001-11-15
JP2003532733A (ja) 2003-11-05
ATE270295T1 (de) 2004-07-15
DE60104110D1 (de) 2004-08-05
EP1282625B1 (en) 2004-06-30
PT1282625E (pt) 2004-10-29
EP1282625A1 (en) 2003-02-12
AU2001251662A1 (en) 2001-11-20
DK1282625T3 (da) 2004-11-15

Similar Documents

Publication Publication Date Title
CO5550421A2 (es) Derivados de indol utiles para el tratamiento de enfermeda- des
PE20010964A1 (es) Derivados de tiazolilamida
DK0862567T3 (da) 5-azabicyclo[3.1.0]hexylalkyl-2-piperidoner og-glutarimider som neurokininreceptorantagonister
JO2668B1 (en) Isoxazolines For Controlling Invertebrate Pests
ES2141137T3 (es) Agentes terapeuticos para la enfermedad de parkinson.
PT1003725E (pt) Fungicidas de fluoropirazoldifenilamidas
HRP20090162T1 (en) Quinolinone-carboxamide compounds as 5-ht4 receptor agonists
BRPI0608732A2 (pt) composto ou um sal, hidrato, solvato, complexo ou pró-droga farmaceuticamente aceitável do mesmo, sal de um composto, processo para a preparação de um composto, uso de um composto, composição farmacêutica, e, produto
BG108207A (en) Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
DK1200426T3 (da) Substituerede thien-3-yl-sulfonylamino(thio)carbonyl-tiazolin(thi)oner
MXPA03000450A (es) Sulfonamidas de ciclilamina como agonistas del receptor adrenergico beta-3.
AU2002231122A1 (en) Methods of treating anxiety disorders
DK0635015T3 (da) Acylaminoindolderivater som 5-Htl agonister
TW200700398A (en) Substituted n-sulfonylaminophenylethyl-2-phenoxyacetamide compounds
BR0314844A (pt) Novo composto
BR0314843A (pt) Novo composto
MX2007005709A (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos.
PT1204658E (pt) Agonistas benzofurilpiperazina de serotonina
DE60121048D1 (de) PYRAZINOi1'2':1,6öPYRIDOi3,4-BöINDOLDERIVATE
PE20040172A1 (es) Imidazolinilmetil aralquilsulfonamidas
PT1282625E (pt) Benzoxazinas para utilizacao no tratamento da doenca de parkinson
BRPI0512086A (pt) composto e os sais farmacologicamente aceitáveis do mesmo, composição farmacêutica, e, processo para a preparação de compostos
KR960037677A (ko) 4-인돌릴피페라지닐 유도체
CO5170464A1 (es) Derivados de 1-trifluorometil-4-hidroxi-7-piperidinil- aminometilcromano
TW354780B (en) 2-disubstituted cyclohexenyl and cyclohexyl antimicrobial agents

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO DA RPI 2016 DE 25/08/2009.